Filing Details

Accession Number:
0001140361-20-023907
Form Type:
4
Zero Holdings:
No
Publication Time:
2020-10-28 06:02:15
Reporting Period:
2020-10-27
Accepted Time:
2020-10-28 06:02:15
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1822462 Foghorn Therapeutics Inc. FHTX () C0
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1362558 Authority Investment Dhabi Abu 211 Corniche Street
Po Box 3600
Abu Dhabi C0 0000
No No No No
1790748 Ltd Rsc Holding Investment International Platinum 26Th Floor, Al Khatem Tower, Adgm Square
Po Box 25642, Al Maryah Island
Abu Dhabi C0 NA
No No No No
1790749 Ltd Rsc 2018 B Falcon Platinum 26Th Floor, Al Khatem Tower, Adgm Square
Po Box 25642, Al Maryah Island
Abu Dhabi C0 NA
No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2020-10-27 1,081,081 $0.00 1,081,081 No 4 C Direct
Common Stock Acquisiton 2020-10-27 150,000 $16.00 1,231,081 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 C Direct
No 4 P Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Series B Preferred Stock Disposition 2020-10-27 2,000,001 $0.00 1,081,081 $0.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 No 4 C Direct
Footnotes
  1. Upon the closing of the sale of shares of Common Stock of the Issuer to the public in a firm-commitment underwritten public offering pursuant to an effective registration statement under the Securities Act of 1933, as amended, resulting in at least $35,000,000 of gross proceeds to the Issuer, the Series B Preferred Stock converted automatically into Common Stock. Every 1.85 shares of Series B Preferred Stock converted into one share of Common Stock. There was no expiration date for the Series B Preferred Stock.
  2. Platinum Falcon B 2018 RSC Limited ("Platinum Falcon") directly holds the Series B Preferred Stock and the shares of Common Stock received upon conversion of the Series B Preferred Stock. Platinum International Investment Holding RSC Limited ("Platinum Holdings") is the sole owner of Platinum Falcon, and the Abu Dhabi Investment Authority ("ADIA" and, together with Platinum Falcon and Platinum Holdings, the "Reporting Persons") is the sole owner of Platinum Holdings. Therefore, Platinum Holdings and ADIA may also be deemed to beneficially own the Series B Preferred Stock and the shares of Common Stock received upon conversion of the Series B Preferred Stock.
  3. Platinum Falcon directly acquired 143,540 shares of Common Stock. Platinum Holdings and ADIA may also be deemed to beneficially own such shares of Common Stock. ADIA acquired directly 6,460 shares of Common Stock, and Platinum Holdings and Platinum Falcon disclaim beneficial ownership of such shares.